| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $28,770,183 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM144117 | Construction of in vivo mRNA delivery systems | 000 | 6 | NIH | 1/16/2026 | $418,275 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH129306 | Epigenetic Mechanisms of Chronic Stress Action | 000 | 4 | NIH | 12/9/2025 | $674,536 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 000 | 3 | NIH | 12/9/2025 | $477,398 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AR078857 | Role of TNFalpha in discogenic pain progression and as a treatment target | 000 | 5 | NIH | 12/17/2025 | $576,100 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG078657 | Identifying genetically driven gene dysregulation in Alzheimer's disease and related dementias using statistical data integration | 000 | 4 | NIH | 12/23/2025 | $603,742 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI168004 | Role of Class IIa HDACs HDAC4 and HDAC7 in Pathogenic Th17 Cell Development and Colitis | 000 | 5 | NIH | 1/16/2026 | $422,500 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UH3TR004040 | Using electronic medical record data to shorten diagnostic odysseys for rare genetic disorders in children and adults in two New York City health care settings | 000 | 5 | NIH | 1/16/2026 | $425,804 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 000 | 4 | NIH | 12/8/2025 | $468,806 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK118222 | Mechanosensitive determinants of podocyte physiology | 000 | 7 | NIH | 1/8/2026 | $725,168 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 000 | 5 | NIH | 12/30/2025 | $582,537 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37AI188431 | Understanding the Tropism and Pathogenesis of Pararubulaviruses | 000 | 2 | NIH | 11/28/2025 | $830,282 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK137968 | The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention study | 000 | 3 | NIH | 12/22/2025 | $729,507 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI187731 | CRISPR-Cas9 base editing approaches to discover ubiquitination events promoting flavivirus infection | 000 | 2 | NIH | 12/1/2025 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK131525 | Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | 000 | 5 | NIH | 12/23/2025 | $841,127 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA154947 | Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | 000 | 15 | NIH | 12/17/2025 | $578,878 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 001 | 2 | NIH | 1/13/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK064640 | Transcription factors in kidney development | 000 | 21 | NIH | 12/18/2025 | $688,041 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K12ES033594 | Scholars in Environmental Pediatrics, Reproductive Health, and Life Course Science | 000 | 5 | NIH | 12/31/2025 | $481,564 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK124133 | Uncovering the rules of gut microbiome strain transmission | 000 | 7 | NIH | 1/8/2026 | $617,193 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI179598 | Determinants of HIV latency in CD4+ T lymphocytes | 000 | 3 | NIH | 12/5/2025 | $844,304 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA244948 | Genetic Predictors of Prostate Cancer Survival | 000 | 6 | NIH | 12/22/2025 | $439,834 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG072489 | Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease | 000 | 5 | NIH | 12/18/2025 | $1,057,227 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA289009 | Lineage evolution of a small cell lung cancer epigenomic subtype signified by NKX2-1 | 000 | 2 | NIH | 12/8/2025 | $615,859 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI174902 | Integration of adjuvant derived nanoparticles and engineered mRNA for HIV vaccine discovery | 000 | 4 | NIH | 1/8/2026 | $836,830 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 000 | 3 | NIH | 12/2/2025 | $633,533 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31HD111230 | Germline Stem Cell Establishment and the Role of Dazl in Gametogenesis | 000 | 3 | NIH | 11/24/2025 | $47,938 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K00CA274650 | Defining tumor and blood-based immunogenomic signatures predicting response to immunotherapy in ovarian cancer | 000 | 4 | NIH | 12/18/2025 | $87,796 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH132786 | Dynamic Neural Computations Underlying Cognitive Control in Bulimia Nervosa | 000 | 4 | NIH | 12/5/2025 | $803,489 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS136202 | Investigating Mechanisms of Neurological Post Acute Sequelae of SARS CoV2 Using Quantitative Multiparametric In-Vivo and Ex-Vivo MRI | 000 | 2 | NIH | 12/19/2025 | $573,253 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AI189255 | Probing the Role of Secondary Lymphoid Tissue Architecture in HIV-1 Associated NLRP3 Inflammasome Signaling | 000 | 2 | NIH | 12/2/2025 | $48,538 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01NS126736 | Administrative Supplement for FXTAS key molecular pathways converge with other neurodegenerative disorders | 000 | 4 | NIH | 1/14/2026 | $53,687 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $552,728 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $163,927 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS106229 | Harnessing YAP-TEAD Activity as Anti-Invasion Therapeutic in Human Glioblastoma | 000 | 7 | NIH | 1/9/2026 | $581,154 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 000 | 3 | NIH | 1/13/2026 | $518,142 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31ES037211 | Perinatal metal mixture exposure and prenatal maternal stress: Impact on neural and cognitive constructs underlying adolescent risk-taking | 000 | 2 | NIH | 12/30/2025 | $49,538 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 001 | 3 | NIH | 1/19/2026 | $69,858 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS143073 | Mapping the Epigenomic and Spatial Transcriptomic Landscape in Parkinson's Disease | 000 | 1 | NIH | 1/19/2026 | $670,266 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AG073148 | A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | 000 | 5 | NIH | 1/6/2026 | $2,321,095 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI168178 | Structural interrogation of vaccine- and infection-induced B cell responses | 000 | 5 | NIH | 1/6/2026 | $780,825 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138025 | microRNA-controlled mRNA therapeutics | 000 | 3 | NIH | 1/16/2026 | $559,205 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH116900 | Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity | 000 | 8 | NIH | 12/22/2025 | $844,899 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32MH136726 | Norepinephrine-sensing habenular microglia and stress-related behaviors | 000 | 2 | NIH | 1/12/2026 | $52,027 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R00HD108392 | Disruption of three-dimensional genome organization as a noncoding mechanism of disease in human developmental disorders | 000 | 4 | NIH | 1/12/2026 | $223,044 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK141891 | Manufacture of defined live microbial therapeutics for infectious and inflammatory disease | 000 | 2 | NIH | 1/19/2026 | $671,511 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 000 | 9 | NIH | 1/13/2026 | $2,510,205 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AG079492 | The regulation of the microglial response to amyloid-beta plaques by the polycomb repressive complex 2 | 000 | 4 | NIH | 1/14/2026 | $54,538 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AG079492 | The regulation of the microglial response to amyloid-beta plaques by the polycomb repressive complex 2 | 001 | 4 | NIH | 1/16/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 3 | NIH | 1/16/2026 | $618,621 |
|
